Trends in Accuracy and Comprehensiveness of Pathology Reports for Resected NSCLC in a High Mortality Area of the United States

Abstract

Introduction: Complete and accurate pathology reports are vital to postoperative prognostication and management. We evaluated the impact of three interventions across a diverse group of hospitals on pathology reports of postresection NSCLC.Methods: We evaluated pathology reports for patients who underwent curative-intent surgical resection for NSCLC, at 11 institutions within four contiguous Dartmouth Hospital Referral Regions in Arkansas, Mississippi, and Tennessee from 2004 to 2020, for completeness and accuracy, before and after the following three quality improvement interventions: education (feedback to heighten awareness); synoptic reporting; and a lymph node specimen collection kit. We compared the proportion of pathology reports with the six most important items for postoperative management (specimen type, tumor size, histologic type, pathologic [p] T-category, pN-category, margin status) across the following six patient cohorts: preintervention control, postintervention with four different combinations of interventions, and a contemporaneous nonintervention external control.Results: In the postintervention era, the odds of reporting all key items were eight times higher than those in the preintervention era (OR ¼ 8.3, 95 % confidence interval [CI]: 6.7-10.2, p < 0.0001). There were sixfold and eightfold increases in the odds of accurate pT-and pN-category reporting in the postintervention era compared with the preintervention era (pT OR ¼ 5.7, 95 % CI: 4.7-6.9; pN OR ¼ 8.0, 95 % CI: 6.5-10.0, both p < 0.0001). Within the intervention groups, the odds of reporting all six key items, accurate pT category, and accurate pN-category were highest in patients who received all three interventions.Conclusions: Gaps in the quality of NSCLC pathologic reportage can be identified, quantified, and corrected by rationally designed interventions.

Overexpression of miR-328-5p influences cell growth and migration to promote NSCLC progression by targeting LOXL4

“…These results showed that, in NSCLC, miR-328-5p is a novel tumor suppressor by targeting LOXL4. With a high incidence and poor survival rates, NSCLC has been the leading cause of cancer-associated mortality worldwide (1,2,17). NSCLC can be divided into 2 major categories, namely squamous cell carcinoma and adenocarcinoma.…”

Surgical Treatment is Still Recommended for Patients Over 75 Years with IA NSCLC: A Predictive Model Based on Surveillance, Epidemiology and End Results Database

“…Lung cancer is 1 of the most common malignancies worldwide, with high morbidity and mortality. 1 Non-small cell lung cancer (NSCLC) is accountable for more than 80% of lung cancer cases. 2 In the past decades, due to the neglect of health and the constraints of economic and technical conditions, most of lung cancer were found to be in the middle and advanced stage, and the treatment prognosis was poor.…”